title: Experience with home aerosolized pentamidine treatment in patients with AIDS.
abstract: Pneumocystis carinii pneumonia (PCP is the most frequent opportunistic infection in patients with AIDS and is the most common cause of death in these patients. Conventional parenteral trimethoprim/sulfamethoxazole or parenteral pentamidine treatment is often not completed because of frequent incidence of adverse reactions. Aerosolized pentamidine appears to be better tolerated and is considered an alternative treatment for PCP in both hospital and community settings. This report describes our experience with 34 patients with AIDS who received aerosolized pentamidine at home. All patients were over 18 years old and had received either parenteral or aerosolized pentamidine within a medically supervised setting before home treatment was initiated. The Respigard II nebulizer system powered by an oxygen source was used as the delivery system. All patients took two puffs of metaproterenol sulfate 10 minutes prior to two 15-minute sessions of pentamidine inhalation. No relapse or adverse reactions were observed in patients. Large randomized clinical trials currently are underway to compare the value of aerosolized pentamidine with other forms of treatment for PCP.
authors.affiliation: Maryland Branch, New England Critical Care, Columbia, MD 21046.
authors.forename: F N
authors.initials: FN
authors.lastname: Choy
authors.forename: D C
authors.initials: DC
authors.lastname: Wilson
authors.forename: G S
authors.initials: GS
authors.lastname: Willcox
authors.forename: K S
authors.initials: KS
authors.lastname: Crocker
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D000336:Aerosols; D006699:Home Care Services; D006801:Humans; D009330:Nebulizers and Vaporizers; D010349:Patient Compliance; D010419:Pentamidine / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000336:Aerosols; D010419:Pentamidine